|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 233/56 | (2006.01) |
| C07D 401/04 | (2006.01) | ||
| C07D 401/14 | (2006.01) | ||
| A61K 31/4436 | (2006.01) | ||
| A61K 31/4164 | (2006.01) | ||
| A61P 31/12 | (2006.01) |
| (11) | Number of the document | 2807151 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13703675.2 |
| Date of filing the European patent application | 2013-01-24 | |
| (97) | Date of publication of the European application | 2014-12-03 |
| (45) | Date of publication and mention of the grant of the patent | 2015-11-18 |
| (46) | Date of publication of the claims translation | 2016-02-10 |
| (86) | Number | PCT/US2013/022997 |
| Date | 2013-01-24 |
| (87) | Number | WO 2013/112741 |
| Date | 2013-08-01 |
| (30) | Number | Date | Country code |
| 201261591710 P | 2012-01-27 | US |
| (72) |
NOTTE, Gregory, US
|
| (73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Apoptozės signalą reguliuojantis kinazės inhibitorius |
| APOPTOSIS SIGNAL-REGULATING KINASE INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2024-12-19 | 13 | 289.00 EUR |
| 2026-01-24 |